Federated Hermes, Inc. Harpoon Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.82 $944 - $1,408	-1,718 Reduced 60.26%	1,133 $0
Q1 2023 May 08, 2023	BUY	$0.65 - $1.37 $117 - $246	180 Added 6.74%	2,851 $2,000
Q4 2022 Feb 13, 2023	BUY	$0.6 - $1.41 $206 - $485	344 Added 14.78%	2,671 $1,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $2.56 $122,636 - $333,987	-130,464 Reduced 98.25%	2,327 $2,000
Q2 2022 Aug 15, 2022	BUY	$1.78 - $5.02 $73,357 - $206,884	41,212 Added 45.0%	132,791 $254,000
Q1 2022 May 13, 2022	SELL	$3.54 - $8.08 $128,222 - $292,665	-36,221 Reduced 28.34%	91,579 $455,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $1,263 - $1,738	-222 Reduced 0.17%	127,800 $965,000
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $1,788 - $3,178	-227 Reduced 0.18%	128,022 $1.01 Million
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $1.77 Million - $2.98 Million	128,080 Added 75786.98%	128,249 $1.78 Million
Q1 2021 May 13, 2021	BUY	$17.65 - $24.16 $2,982 - $4,083	169 New	169 $4,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.